.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chubb
Queensland Health
QuintilesIMS
McKesson
Cerilliant
Mallinckrodt
Cantor Fitzgerald
McKinsey
Harvard Business School

Generated: December 16, 2017

DrugPatentWatch Database Preview

EQUANIL Drug Profile

« Back to Dashboard

When do Equanil patents expire, and when can generic versions of Equanil launch?

Equanil is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in EQUANIL is meprobamate. There are twenty-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the meprobamate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth AyerstEQUANILmeprobamateCAPSULE;ORAL012455-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth AyerstEQUANILmeprobamateTABLET;ORAL010028-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth AyerstEQUANILmeprobamateTABLET;ORAL010028-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Novartis
Queensland Health
Harvard Business School
Mallinckrodt
Colorcon
Express Scripts
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot